QC
Quantessence Capital Portfolio holdings
AUM
$340M
This Quarter Return
+5.34%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$400M
AUM Growth
+$400M
(+64%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
38.92%
Top 10 Holdings %
Top 10 Hldgs %
29.1%
Holding
490
New
266
Increased
41
Reduced
24
Closed
158
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$30.3M |
| 2 |
The Communication Services Select Sector SPDR Fund
XLC
|
$12.3M |
| 3 |
Pfizer
PFE
|
$10.6M |
| 4 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
$10.5M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
$10.2M |
Top Sells
| 1 |
iShares US Real Estate ETF
IYR
|
$11.2M |
| 2 |
International Paper
IP
|
$11.1M |
| 3 |
UMB Financial
UMBF
|
$6.83M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
$6.69M |
| 5 |
Meta Platforms (Facebook)
META
|
$6.46M |
Sector Composition
| 1 | Healthcare | 24.24% |
| 2 | Financials | 15.65% |
| 3 | Technology | 11.73% |
| 4 | Industrials | 10.46% |
| 5 | Consumer Staples | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Mativ Holdings
MATV
$672M
| $209K | 0.05% |
+33,500
| New | +$209K |
|
277
Ambac
AMBC
$409M
| $206K | 0.05% |
+23,500
| New | +$206K |
|
|
CNR
278
Core Natural Resources, Inc.
CNR
$3.7B
| $205K | 0.05% |
+2,660
| New | +$205K |
|
279
Regal Rexnord
RRX
$9.75B
| $205K | 0.05% |
+1,800
| New | +$205K |
|
280
Mr. Cooper
COOP
$11.6B
| $203K | 0.05% |
+1,700
| New | +$203K |
|
281
Perdoceo Education
PRDO
$2.12B
| $201K | 0.05% |
+8,000
| New | +$201K |
|
282
Par Pacific Holdings
PARR
$1.78B
| $187K | 0.05% |
+13,100
| New | +$187K |
|
|
ATYR
283
aTyr Pharma
ATYR
$544M
| $186K | 0.05% |
+61,621
| New | +$186K |
|
284
ClearPoint Neuro
CLPT
$289M
| $185K | 0.05% |
+15,582
| New | +$185K |
|
|
NESR
285
National Energy Services Reunited Corp. Ordinary Shares
NESR
$934M
| $179K | 0.04% |
+24,339
| New | +$179K |
|
|
TTAM
286
Titan America SA
TTAM
$2.82B
| $178K | 0.04% |
+13,165
| New | +$178K |
|
287
Ginkgo Bioworks
DNA
$653M
| $174K | 0.04% |
+30,550
| New | +$174K |
|
288
Fulgent Genetics
FLGT
$680M
| $171K | 0.04% |
+10,100
| New | +$171K |
|
289
eXp World Holdings
EXPI
$1.67B
| $154K | 0.04% |
+15,700
| New | +$154K |
|
290
Helix Energy Solutions
HLX
$960M
| $151K | 0.04% |
+18,200
| New | +$151K |
|
291
Gevo
GEVO
$409M
| $142K | 0.04% |
+122,614
| New | +$142K |
|
292
Amylyx Pharmaceuticals
AMLX
$860M
| $142K | 0.04% |
+40,134
| New | +$142K |
|
|
LOGC
293
DELISTED
ContextLogic
LOGC
| $139K | 0.03% |
+19,855
| New | +$139K |
|
294
Titan International
TWI
$555M
| $138K | 0.03% |
+16,500
| New | +$138K |
|
295
Oportun Financial
OPRT
$280M
| $137K | 0.03% |
+24,910
| New | +$137K |
|
296
Protalix BioTherapeutics
PLX
$132M
| $131K | 0.03% |
+51,243
| New | +$131K |
|
297
Gossamer Bio
GOSS
$596M
| $130K | 0.03% |
+118,349
| New | +$130K |
|
298
Roivant Sciences
ROIV
$8.39B
| $126K | 0.03% |
+12,513
| New | +$126K |
|
299
Abeona Therapeutics
ABEO
$352M
| $124K | 0.03% |
+26,087
| New | +$124K |
|
300
Expensify
EXFY
$177M
| $122K | 0.03% |
+40,000
| New | +$122K |
|